Postoperative Adjuvant Chemoradiotherapy in Older Patients with Head and Neck Cancer

Archives of Otolaryngology - Head and Neck Surgery

Volumn 130, Issue 2, 2004, Pages 161-166

  Airoldi, Mario ^a   Cortesina, Giorgio ^b   Giordano, Carlo ^b   Pedani, Fulvia ^a   Gabriele, Anna Maria ^a   Marchionatti, Sara ^a   Bumma, Cesare ^a  

^a MOLINETTE HOSPITAL   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN;

AGED; ANEMIA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CLASSIFICATION; CANCER INVASION; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DERMATITIS; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHARYNX CANCER; LARYNX CANCER; MALE; MOUTH CANCER; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NAUSEA; NEUTROPENIA; OROPHARYNX CANCER; OUTCOMES RESEARCH; PERINEURIUM; PERIPHERAL NEUROPATHY; POSTOPERATIVE CARE; PROGNOSIS; RADIATION DOSE FRACTIONATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; THROMBOCYTOPENIA; TREATMENT FAILURE; VASCULAR DISEASE; VOMITING;

AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASMS, SQUAMOUS CELL; PATIENT COMPLIANCE; QUALITY OF LIFE; RADIOTHERAPY, ADJUVANT; SURVIVAL RATE;

EID: 0842300317     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.130.2.161     Document Type: Article

References (26)

1. Looser KG, Shah JP, Strong EW. The significance of positive margins in surgically resected epidermoid carcinomas. Head Neck Surg. 1978;1:107-111.
2. Van den Bogaert W, Osyn F, Van der Schueren E. The different clinical presentations, behaviour and prognosis of carcinomas originating in the epilarynx and the lower supraglottis. Radiother Oncol. 1983;1:117-131.
3. Snow GB, Annyas AA, van Slooten EA, Bartelink H, Hart AA. Prognostic factors of neck node metastasis. Clin Otolaryngol. 1982;7:185-192.
4. Grandi C, Alloisio M, Moglia D. Prognostic significance of lymphatic spread in head and neck carcinomas: therapeutic implications. Head Neck Surg. 1985;8:67-73.
5. Million RR, Cassisi NJ. General principles for treatment of cancers of the head and neck: the primary site. In: Management of Head and Neck Cancer: A Multidisciplinary Approach. Philadelphia, Pa: JB Lippincott; 1994:61-74.
6. Agarwala SS. Adjuvant chemotherapy in head and neck cancer. Hematol Oncol Clin North Am. 1999;13:743-752.
7. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma. J Natl Cancer Inst. 1999;91:2081-2086.
8. Brizel DM, Albers ME, Fisher SR, et al. Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med. 1998;338:1798-1804.
9. Adelstein DJ, Saxton JP, Lavertu P, et al. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in resectable stage III and IV squamous cell head and neck cancer: preliminary results. Head Neck. 1997;19:567-575.
10. Wendt TG, Grabenbauer GG, Rodel CM, et al. Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer. J Clin Oncol. 1998;16:1318-1324.
11. Pignon JP, Bourhis J, Domenge C, Designe L, MACH-NC Collaborative Group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data: Meta-analysis of Chemotherapy on Head and Neck Cancer. Lancet. 2000;355:949-955.
12. Haffty BG, Son YH, Sasaki CT, et al. Mitomycin C as an adjunct to postoperative radiation therapy in squamous cell carcinoma of the head and neck: results from two randomized clinical trials. Int J Radiat Oncol Biol Phys. 1993;27:241-250.
13. Weissberg JB, Son YH, Papac RJ, et al. Randomized clinical trial of mitomycin C as an adjunct to radiotherapy in head and neck cancer. Int J Radiat Oncol Biol Phys. 1989;17:3-9.
14. Weissler MC, Melin S, Sailer SL, et al. Simultaneous chemoradiation in the treatment of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg. 1992;118:806-810.
15. Bachuad JM, Cohen-Jonathan E, Alizieu C, et al. Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced head and neck carcinoma: final report of a randomized trial. Int J Radiat Oncol Biol Phys. 1996;36:999-1004.
16. Bernier J, van Glabbeke M, Domenge C, et al. Results of the EORTC phase III trial 22931 comparing, postoperatively, radiotherapy to concurrent chemoradiotherapy with high dose cisplatin in locally advanced head and neck carcinomas. Eur J Cancer. 2001;37(suppl 6):267. Abstract 989.
17. Cooper JS, Pajak TF, Forastiere AA, et al. Postoperative concurrent radiochemotherapy in high-risk SCCA of the head and neck: initial report of RTOG 9501/Intergroup phase III trial. Proc Am Soc Clin Oncol. 2002;21:226. Abstract 903.
18. Cella DF. Manual of the Functional Assessment of Cancer Therapy (FACT) Measurement System, Version 3. Chicago, Ill: Rush Medical Center; 1994.
19. National Cancer Institute. Criteria Manual, Version 2.0. Bethesda, Md: National Cancer Institute; 1999.
20. Airoldi M, Gabriele P, Ruo Redda MG, et al. Post-operative concurrent carboplatin and radiotherapy in patients with poor prognosis head and neck carcinoma. Tumori. 1997;83(suppl 1):109. Abstract 317.
21. Balducci L, Extermann M. Cancer and aging: an evolving panorama. Hematol Oncol Clin North Am. 2000;14:1-16.
22. Airoldi M, Orecchia R, Gabriele P, et al. Carboplatin + radiotherapy vs radiotherapy in inoperable stage III-IV head and neck carcinoma. Eur J Cancer. 1997;33(suppl 8):187. Abstract 841.
23. Cattel L, Recalenda V, Airoldi M, et al. A preliminary pharmacokinetic study of docetaxel, carboplatin and concurrent radiotherapy for regionally advanced squamous cell carcinoma of the head and neck. Farmaco. 2001;56:695-699.
24. Pignon T, Horiot JC, Van den Bogaert W, Van Glabbeke M, Scalliet P. No age limit for radical radiotherapy in head and neck tumours. Eur J Cancer. 1996;32A:2075-2081.
25. Allal AS, Maire D, Becker M, et al. Feasibility and early results of accelerated radiotherapy for head and neck carcinoma in the elderly. Cancer. 2000;88:648-652.
26. Balducci L, Extermann M. Management of cancer in the older person: a practical approach. Oncologist. 2000;5:224-237.